No popular authors found.
Ads by Google:

Categories

No categories found.


Get Celiac.com's E-Newsletter





Ads by Google:


Follow / Share


  FOLLOW US:
Twitter Facebook Google Plus Pinterest RSS Podcast Email  Get Email Alerts
SHARE:

Popular Articles

No popular articles found.
Celiac.com Sponsors:

ImmunogenX Continues Developing New Treatment Options for Celiac Disease

Jennifer A. Sealey-Voyksner, PhD Chief Scientific Officer and Co-Founder of ImmunogenX provides a progress update on a potential new treatment for celiac disease.


Image: CC--Idaho National Laboratory

Celiac.com 08/11/2017 - We are very pleased to provide an exciting update on our progress on bringing our therapeutic drug "latiglutenase" and our diagnostic disease management tool "CypCel" to market for patients suffering with celiac disease.

ImmunogenX is a clinical-stage company founded by dedicated scientists committed to bettering the lives of celiac disease patients. We are focused on celiac disease therapy, disease management and food safety. We acquired the assets of Alvine Pharmaceuticals in 2016 and are marching ahead with great confidence and enthusiasm and plan to start our final Phase 2 trial for latiglutenase later this year.

Latiglutenase is a natural product, a mixture of two gluten-specific enzymes that break down gluten in the stomach. A patient would take the therapy orally while maintaining a strict gluten-free diet. The intent of the therapy is to combat low levels of gluten that persist in the food chain, as well as in situations where ingestion of gluten is unavoidable due to cross contamination, such as at restaurants.

Ads by Google:

The recent latiglutenase Phase 2b trial (CeliAction) conducted by Alvine and AbbVie unfortunately did not meet their primary goal of demonstrating clinically significant intestinal healing. The secondary goal of symptom reduction did show evidence of success in a subclass of celiac disease patients. ImmunogenX, following the acquisition of the Alvine assets, completed a post hoc data analysis from this trial. Statistically and clinically significant symptom improvement was shown for abdominal pain, bloating, tiredness, and constipation for patients who had persistent positive readings in key antibody levels (i.e., seropositive). These exciting results were highlighted at the Digestive Disease Week meeting in May 2017 and are now published in Digestive Diseases and Sciences. We will travel to India in September to present our research at ICDS 2017 (International Celiac Disease Symposium).

If the primary endpoint of the CeliAction trial had been focused on reducing symptoms of gluten exposure, then that trial could rightfully have been called a success. Therefore, as a next step, ImmunogenX will be to go back into the clinic and reconfirm these positive results, demonstrating symptom improvement, in our next phase 2 trial. This will enable the company to transition to a pivotal trial for FDA registration.

We attended another FDA Type C meeting in May 2017, which reinforced the continuing positive support from the agency regarding our symptom label, our Phase 2/3 trial strategy and our celiac disease symptom diary (CDSD) patient reported outcome (PRO) instrument. It is very gratifying to have such documented support from the FDA for our mission.

Please visit our website www.immunogenx.com for updates on our progress and feel free to contact us with any questions (info@immunogenx.com).

Celiac.com welcomes your comments below (registration is NOT required).












Related Articles



4 Responses:

 
Rick Stiles
Rating: ratingfullratingfullratingfullratingfullratingfull Unrated
said this on
14 Aug 2017 8:06:05 AM PDT
Thank you for reporting negative results! These are incredibly important in steering research toward success. And congrats on the positive results your team has made. Millions of celiacs are looking forward with hope to what labs like yours will produce.

 
Deb
Rating: ratingfullratingfullratingfullratingfullratingempty Unrated
said this on
14 Aug 2017 12:19:18 PM PDT
So, this article is saying they are going for symptom relief not blocking actual damage done? Long term effects of malnutrition from damaged villi can lead to life threatening and debilitating symptoms, and the damage can lead, also, to cancer. This does not sound like anything a person with celiac should rely on for actual health, so why is it being called a celiac treatment?

 
admin
( Author)
said this on
14 Aug 2017 1:32:32 PM PDT
Their approach would prevent the damage as well.

 
Karen
Rating: ratingfullratingfullratingfullratingfullratingempty Unrated
said this on
14 Aug 2017 5:15:18 PM PDT
Being that I am recovering from an accidental glutening right now I find this news exciting and encouraging. Thank you for the honest sharing of both positive and negative results.




Rate this article and leave a comment:
Rating: * Poor Excellent
Your Name *: Email (private) *:




In Celiac.com's Forum Now:


Hi David, there are 3 different conditions basically: Celiac disease, non celiac gluten sensitivity and wheat allergy. Celiac disease - blood tests: Gliadin IgG Gliadin IgA Endomysium IgG Endomysium IgA ttg IgG ttG IgA total IgA - this is not a celia...

Is non-celiac wheat sensitivity a persistent condition? A team of researchers recently set out to assess how many patients with a diagnosis of non-celiac wheat sensitivity (NCWS) still experienced symptoms of wheat sensitivity after an average follow-up time of 99 months. Using data collected fr...

Well, the biopsy came back just plain old reflux/esophagitis. No EoE. This is reassuring in some ways for me. I didn't really want to give up ice cream! I hope that a gluten-free diet clears up your symptoms for you. For me, I guess it's just no evening snacking, less coffee, smaller meals. ...

Curious, has anyone had, as a symptom, periods of being incredibly thirsty, even though you've been drinking plenty of water? Sometimes I feel dehydrated. I don't have diabetes, I do know that can be a symptom of that condition.

Hi, wasn't sure where to really put this. UK website Coeliac Sanctuary do travel cards in 44 languages which are all professionally translated and credit card sized, wristbands for Coeliac and Gluten Intolerance and a gluten free recipe calendar. They are UK based but ship internationally too. A...